Pancreatic adenocarcinoma displayed strong nuclear immunoreactivity for HDAC1 (32%), HDAC2 (63%), HDAC3 (79%) and RelA/p65 (45%) in a considerable number of cases (Figure 1). The gene discussed is HDAC2; the disease is pancreatic adenocarcinoma.